RT Journal Article
SR Electronic
T1 Activation of the UPR is necessary and sufficient for reducing topoisomerase II α protein levels and decreasing sensitivity to topoisomerase targeted drugs
JF Molecular Pharmacology
JO Mol Pharmacol
FD American Society for Pharmacology and Experimental Therapeutics
DO 10.1124/mol.105.014753
A1 Miranda D. Gray
A1 Melissa Mann
A1 John L. Nitiss
A1 Linda M. Hendershot
YR 2005
UL http://molpharm.aspetjournals.org/content/early/2005/09/01/mol.105.014753.abstract
AB